Search for: "MAXIM PHARMACEUTICALS, INC." Results 1 - 20 of 146
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Dec 2020, 10:31 pm
 Jane LambertPatents Court (Mr Justice Birss) Regeneron Pharmaceuticals, Inc. and another v Rinat Neuroscience Corp. [2020] EWHC 3359 (Pat) (7 Dec 2020)Interest rei publicae ut sit finis litium. [read post]
28 May 2007, 8:21 pm
American Conference Institute will hold the 2nd west coast edition of its popular "Maximizing Pharmaceutical Patent Life Cycles" conference next week in San Francisco (at the beautiful Mark Hopkins hotel). [read post]
5 Dec 2011, 8:59 am by Kara M. Maciel
Abbott Laboratories, Inc., the Eastern District of Pennsylvania issued the latest ruling in the ongoing dispute over whether pharmaceutical sales representatives are exempt from the overtime requirements of the FLSA. [read post]
5 Dec 2011, 8:59 am by <a href=''>Kara M. Maciel</a>
Abbott Laboratories, Inc., the Eastern District of Pennsylvania issued the latest ruling in the ongoing dispute over whether pharmaceutical sales representatives are exempt from the overtime requirements of the FLSA. [read post]
5 Oct 2020, 9:13 am by Silver Law Group
Our team of lawyers, accountants investigators work with you to help maximize your recovery. [read post]
6 Jan 2014, 6:45 am by David Jensen
He said pharmaceutical makers such as Teva Pharmaceutical Industries Ltd. [read post]
3 Jan 2012, 6:04 pm
The Department of Justice recently settled allegations with pharmaceutical giant GE Healthcare Inc. that a company that it had acquired in 2004, Amersham Health, Inc. [read post]
16 Sep 2010, 3:57 am by LaBovick Law
American pharmaceutical manufacturer Allergan Inc. has agreed to plead guilty and pay $600 million fine. [read post]
11 Apr 2019, 12:14 pm by Renae Lloyd
If you have suffered investment losses in Environmental Packaging Technologies Holdings, Inc. and CURE Pharmaceutical Holding Corp. or another microcap stock, you may be able to recover your losses. [read post]
9 Mar 2009, 7:24 pm
Wyeth Company may be extremely sensitive to this decision as rival pharmaceutical company Pfizer Inc. is expected to buy out Wyeth for $68 billion later this year. [read post]
2 Oct 2013, 6:00 am by John Ottaviani
·               Mnemosyne Pharmaceuticals Inc., of Providence, received a $5,166,000 early stage investment from existing investors Atlas Venture Advisors Inc. and Clol Biotechnology Industries, Ltd. [read post]
2 Oct 2013, 6:00 am by John Ottaviani
·               Mnemosyne Pharmaceuticals Inc., of Providence, received a $5,166,000 early stage investment from existing investors Atlas Venture Advisors Inc. and Clol Biotechnology Industries, Ltd. [read post]